Search

everythinglearnresearchcommunity

for

Search:↓

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Bone Morphogenetic Proteins (BMPs) help control skin health, hair growth, and color, and could potentially be used to treat skin and hair disorders.

Blocking JAK-STAT signaling can lead to hair growth.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

UV radiation can help sterilize wounds and promote healing but requires careful use to avoid damaging cells.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

PRP treatment may stimulate hair growth by promoting blood vessel formation, increasing growth factors, and preventing cell death.

Smad-4 and Smad-7 are key in hair follicle development, with other Smads being less important.

Kennedy's disease leads to muscle weakness without a cure, but exercise and managing symptoms may help patients live a normal lifespan.

Ephrins slow down skin and hair follicle cell growth.

Valproic acid increases hair count in men with hair loss.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

Topical metformin helped regrow hair in two women with a hard-to-treat scarring hair loss condition.

ATP increases melanin production in skin after UV exposure, with the P2X7 receptor being crucial for this process.

Certain herbal compounds, especially from bitter melon, can inhibit cancer growth and promote hair growth by blocking PAK1.

VEGF stimulates hair cell growth and increases growth receptor levels through a specific signaling pathway.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

The method increases stem-like cells for better skin regeneration.

The African spiny mouse heals skin without scarring due to different protein activity compared to the common house mouse, which heals with scarring.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Man drank minoxidil, caused low blood pressure and fast heartbeat, treatment helped but led to heart damage.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

New treatment with green tea polyphenols and nicotinamide improves skin problems from cancer therapy.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Applying InlB321/15 to wounds sped up healing in mice.